Novo Nordisk said China has approved a five-year patent term extension tied to the chronic kidney disease indication for Ozempic,...
-
-
Recent Updates
- China Europe Innovation Dialogue in Shanghai Highlights Push for Technology Ties
- Novo Nordisk Wins China Patent Extension for Ozempic Kidney Disease Use
- China 3D Printer Maker Raise3D Fuzhi Technology Raises 100 Million Yuan and Unveils Large Format Machines
- China’s AI Ambitions Test US Curbs on Nvidia Chips
- Myanmar Pushes Rare Earth Investment as China Dominates Critical Minerals
- Tesla’s China sales crash 66% to lowest level in over four years
- RELEX Brings AI Supply Chain Tools to China Convenience Store Chain Tangjiu
- I Visited China as an American Without a Visa—Here’s How You Can Do It Too
- Alleged Huang Relationship Draws National Security Concern After Taipei Sighting
- Nvidia Chief’s Alleged Chinese Spy Affair Tests Washington’s AI Race with China
Blogroll